Table 1.
Comparison of basic clinical information and laboratory results of patients with different AMH levels using antagonist regimens.
| Projects | Antagonist regimen (A1) | Antagonist regimen (B1) | Z/t/x² Value | P-value |
|---|---|---|---|---|
| Number of cycles | 54 | 191 | ||
| Female age (years) | 30 (28, 32) | 31.5 (29, 33) | 0.374 | 0.709 |
| Body mass index (kg/m2) | 23.92 ± 0.27 | 23.68 ± 0.26 | -0.732 | 0.465 |
| Years of infertility (years) | 3 (2, 5) | 3(2,5) | 0.007 | 0.995 |
| Anti-Mullerian hormone (ng/ml) | 0.32 (0.24, 0.42) | 0.85(0.71,1.00) | -20.060 | <0.001 |
| Basal FSH (IU/L) | 10(7,16) | 8.32 (6.04, 9.58) | 4.438 | <0.001 |
| Basal E2 (pmol/L) | 160.2 (114.4, 193.8) | 159.05 (119.96, 192.84) | -0.390 | 0.697 |
| Sinus follicle count AFC | 6(4,7) | 8(6,11) | -5.756 | <0.001 |
| Gn initiation volume (U) | 300.0(225.0, 300.0) | 300 (225, 300) | -1.759 | 0.08 |
| Gn usage time (d) | 9 (7.25, 10) | 10 (8, 11) | -2.208 | 0.028 |
| hCG Day | ||||
| The endometrial thickness on hCG day (mm) | 10.19 ± 0.33 | 10.36 ± 0.17 | -0.770 | 0.442 |
| hCG day LH (IU/L) | 3.725 (2.03, 6.27) | 1.8 (1.1125, 2.975) | 5.071 | <0.001 |
| hCG day estradiol (pmol/L) | 2171.5 (898.25, 3991.0) | 3362 (1582, 6232.5) | -4.043 | <0.001 |
| Total number of eggs obtained (pieces) | 3(2,4.75) | 6 (4, 9) | -6.019 | <0.001 |
| 2PN number (pieces) | 2(1,4) | 3 (2, 5) | -4.166 | <0.001 |
| Number of available embryos (pieces) | 2(1,3) | 3 (2, 4) | -4.231 | <0.001 |
| Number of high-quality embryos (pieces) | 1 (0, 1) | 1 (0, 2) | -3.140 | <0.001 |
| Cumulative live birth rate | 22.2% (12/54) | 49.7% (95/191) | 12.957 | <0.001 |
| Optimistic cumulative live birth rate | 22.0% (13/59) | 49.3% (110/223) | 14.133 | <0.001 |
| Conservative cumulative live birth rate | 20.3% (12/59) | 42.6% (95/223) | 9.820 | 0.002 |